Remedy Plan Therapeutics

Gaithersburg, MD · Founded 2012 · Privately Held (backing)

Developer of medical drugs designed to halt tumor growth and prevent cancer. Remedy Plan Therapeutics is based in Gaithersburg, MD and was founded in 2012. Its last reported valuation was $55 million in Aug 2023. It has raised $47.6 million.

Last reported valuation
$55.0M
Oct 2026
Priced at
—
Total raised
$47.6M
Last round
—

Who backs Remedy Plan Therapeutics?

5 investors
InvestorType
Alexandria Venture InvestmentsOther
Schooner CapitalGrowth equity
20/20 HealthCare PartnersFamily office
Maryland Tech Council—
QB3—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Remedy Plan Therapeutics investors

5 investors are on record for Remedy Plan Therapeutics, including Alexandria Venture Investments, Schooner Capital, 20/20 HealthCare Partners and Maryland Tech Council.

Private Market View
More of Remedy Plan Therapeutics with a free Private Market View account
  • ·Watch Remedy Plan Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Remedy Plan Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View